Trial Profile
Clinical Trials Insight: 700045752
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2009
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 Jun 2009 New trial record.
- 19 May 2009 Results have been presented at the 8th European Congress on Menopause according to Daiichi Sankyo media release; results were also reported in the media release.